Celgene Corp. (CELG)

• Annual Data
• Quarterly Data

Celgene Corp., Common-Size Consolidated Income Statement

	12 months ended	Dec 31, 2018		Dec 31, 2017		Dec 31, 2016		Dec 31, 2015		Dec 31, 2014
	Net product sales
	Cost of goods sold, excluding amortization of acquired intangible assets
	Gross profit
	Other revenue
	Research and development
	Selling, general and administrative
	Amortization of acquired intangible assets
	Acquisition related gains (charges) and restructuring, net
	Operating income
	Interest and investment income, net
	Interest expense
	Other income (expense), net
	Other income and expense
	Income before income taxes
	Income tax provision
	Net income

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-07), 10-K (filing date: 2017-02-10), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-20).